Chairman disbands panel investigating COVID-19's origins, saying its links to a nonprofit that worked with a Chinese lab raises bias concerns
- A Lancet-affiliated
scientistpanel studying the origins of COVID-19has been disbanded.
- The chairman of the panel told WSJ he was concerned about its links to EcoHealth Alliance.
- EcoHealth Alliance has been facing scrutiny over its connection to an institute in Wuhan.
A task force of
The Wall Street Journal reported that it was due to the task force's links with US nonprofit EcoHealth Alliance, which worked with the Wuhan Institute of Virology. Sachs said this risked the perception of bias, according to the outlet.
New York-based EcoHealth Alliance focuses on research and has been subjected to intense scrutiny since the onset of the pandemic.
Sachs told the Wall Street Journal of his motivation behind dissolving the task force.
"I just didn't want a task force that was so clearly involved with one of the main issues of this whole search for the origins, which was EcoHealth Alliance," he said.
There is still no conclusive evidence that
EcoHealth Alliance has channeled some of its funding towards the institute, which involved collecting samples from bats and people at risk of infection from bat viruses, The Telegraph previously reported.
That grant was stopped in April 2020 on the orders of then president Trump but was reinstated later in the year, the outlet said.
Daszak led the task force, affiliated with the
Some other members of the task force have worked with Daszak or EcoHealth alliance on projects, the WSJ reported. One member said the disbanded group does not have conflicts of interest that stand in the way of its means to assess data on how the virus jumped to humans.
Sachs told the WSJ that the Lancet COVID-19 Commission would continue to study the origins in a report due to be published in mid-2022. But the commission would widen its scope to include input on biosafety concerns from external experts, including government oversight and transparency on lab research.
He said more labs have the technology to recreate or construct new viruses, but guidance and regulation on safe experimentation aren't keeping pace.
"A lot is going on around the world that is not properly scrutinized or explained to the public," Sachs said. The professor isn't supporting any one theory over another about the origins of COVID-19, he added.
The Lancet task force had been chasing leads on both the natural spillover from an animal and lab-leak hypotheses, WSJ said.
- Byju's has acquired yet another startup, this time from Austria
- HCL Tech, Tata Motors and Nazara Technologies are the top stocks to watch out for on December 9
- An Indian media veteran is building a social media platform just for women after his wife got trolled on Whatsapp
- Not received Tega Industries’ IPO refund? Here are the things you should take a note of
- MapmyIndia’s IPO opens today — GMP at ₹784